Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018

摘要

Question To what extent have manufacturer discounts offset increases in list prices of branded pharmaceutical products in the US? Findings Using 2007-2018 net pricing data on branded pharmaceutical products in the US, list prices increased by 159% and net prices increased by 60%. Discounts increased from 40% in 2007 to 76% in 2018 in Medicaid and increased from 23% to 51% in other payers, offsetting 62% of increases in list prices for drugs. Meaning Although discounts partially offset list price increases of branded products from 2007 to 2018, there was still a substantial increase in net prices over this period.